Histone deacetylase 1 interacts with HIV-1 Integrase and modulates viral replication.
HDAC1
HIV-1
Integrase
Preintegration step
Journal
Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645
Informations de publication
Date de publication:
19 11 2019
19 11 2019
Historique:
received:
22
07
2019
accepted:
05
11
2019
entrez:
21
11
2019
pubmed:
21
11
2019
medline:
29
4
2020
Statut:
epublish
Résumé
HIV-1 hijacks the cellular machinery for its own replication through protein-protein interactions between viral and host cell factors. One strategy against HIV-1 infection is thus to target these key protein complexes. As the integration of reverse transcribed viral cDNA into a host cell chromosome is an essential step in the HIV-1 life cycle, catalyzed by the viral integrase and other important host factors, we aimed at identifying new integrase binding partners through a novel approach. A LTR-derived biotinylated DNA fragment complexed with the integrase on magnetic beads was incubated with extracts from integrase-expressing 293 T cells. Liquid chromatography-mass spectrometry/mass spectrometry and co-immunoprecipitation/pull-down experiments were used for the identification of binding partners. Transfections of histone deacetylase 1 (HDAC1) expression vectors and/or specific siRNA were conducted in HeLa-CD4 and 293 T cells followed by infection with fully infectious NL4-3 and luciferase-expressing pseudotyped viruses or by proviral DNA transfection. Fully infectious and pseudotyped viruses produced from HDAC1-silenced 293 T cells were tested for their infectivity toward HeLa-CD4 cells, T cell lines and primary CD4+ T cells. Late RT species and integrated viral DNA were quantified by qPCR and infectivity was measured by luciferase activity and p24 ELISA assay. Results were analyzed by the Student's t-test. Using our integrase-LTR bait approach, we successfully identified new potential integrase-binding partners, including HDAC1. We further confirmed that HDAC1 interacted with the HIV-1 integrase in co-immunoprecipitation and pull-down experiments. HDAC1 knockdown in infected HeLa cells was shown to interfere with an early preintegration step of the HIV-1 replication cycle, which possibly involves reverse transcription. We also observed that, while HDAC1 overexpression inhibited HIV-1 expression after integration, HDAC1 knockdown had no effect on this step. In virus producer cells, HDAC1 knockdown had a limited impact on virus infectivity in either cell lines or primary CD4+ T cells. Our results show that HDAC1 interacts with the HIV-1 integrase and affects virus replication before and after integration. Overall, HDAC1 appears to facilitate HIV-1 replication with a major effect on a preintegration step, which likely occurs at the reverse transcription step.
Sections du résumé
BACKGROUND
HIV-1 hijacks the cellular machinery for its own replication through protein-protein interactions between viral and host cell factors. One strategy against HIV-1 infection is thus to target these key protein complexes. As the integration of reverse transcribed viral cDNA into a host cell chromosome is an essential step in the HIV-1 life cycle, catalyzed by the viral integrase and other important host factors, we aimed at identifying new integrase binding partners through a novel approach.
METHODS
A LTR-derived biotinylated DNA fragment complexed with the integrase on magnetic beads was incubated with extracts from integrase-expressing 293 T cells. Liquid chromatography-mass spectrometry/mass spectrometry and co-immunoprecipitation/pull-down experiments were used for the identification of binding partners. Transfections of histone deacetylase 1 (HDAC1) expression vectors and/or specific siRNA were conducted in HeLa-CD4 and 293 T cells followed by infection with fully infectious NL4-3 and luciferase-expressing pseudotyped viruses or by proviral DNA transfection. Fully infectious and pseudotyped viruses produced from HDAC1-silenced 293 T cells were tested for their infectivity toward HeLa-CD4 cells, T cell lines and primary CD4+ T cells. Late RT species and integrated viral DNA were quantified by qPCR and infectivity was measured by luciferase activity and p24 ELISA assay. Results were analyzed by the Student's t-test.
RESULTS
Using our integrase-LTR bait approach, we successfully identified new potential integrase-binding partners, including HDAC1. We further confirmed that HDAC1 interacted with the HIV-1 integrase in co-immunoprecipitation and pull-down experiments. HDAC1 knockdown in infected HeLa cells was shown to interfere with an early preintegration step of the HIV-1 replication cycle, which possibly involves reverse transcription. We also observed that, while HDAC1 overexpression inhibited HIV-1 expression after integration, HDAC1 knockdown had no effect on this step. In virus producer cells, HDAC1 knockdown had a limited impact on virus infectivity in either cell lines or primary CD4+ T cells.
CONCLUSIONS
Our results show that HDAC1 interacts with the HIV-1 integrase and affects virus replication before and after integration. Overall, HDAC1 appears to facilitate HIV-1 replication with a major effect on a preintegration step, which likely occurs at the reverse transcription step.
Identifiants
pubmed: 31744547
doi: 10.1186/s12985-019-1249-y
pii: 10.1186/s12985-019-1249-y
pmc: PMC6862858
doi:
Substances chimiques
HIV Integrase
EC 2.7.7.-
HDAC1 protein, human
EC 3.5.1.98
Histone Deacetylase 1
EC 3.5.1.98
p31 integrase protein, Human immunodeficiency virus 1
YY6481J2FF
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
138Références
J Biol Chem. 2012 Nov 30;287(49):40858-66
pubmed: 23043109
EMBO J. 2007 Jan 24;26(2):412-23
pubmed: 17245431
Expert Rev Mol Med. 2007 Feb 26;9(6):1-19
pubmed: 17320002
J Mol Biol. 2011 Jul 29;410(5):847-62
pubmed: 21763491
J Virol. 1997 Mar;71(3):1922-30
pubmed: 9032323
J Virol. 2006 Jun;80(12):5670-7
pubmed: 16731905
J Virol. 2007 Sep;81(18):10037-46
pubmed: 17626089
Retrovirology. 2009 Dec 04;6:111
pubmed: 19961595
Subcell Biochem. 2007;41:193-212
pubmed: 17484129
J Virol. 2014 Sep;88(18):10803-12
pubmed: 25008921
Nat Rev Drug Discov. 2006 Sep;5(9):769-84
pubmed: 16955068
J Biol Chem. 2009 Mar 20;284(12):7931-9
pubmed: 19150986
J Virol. 1995 Nov;69(11):6705-11
pubmed: 7474080
Chembiochem. 2010 Jul 26;11(11):1501-4
pubmed: 20578118
FASEB J. 2000 Jul;14(10):1389-99
pubmed: 10877832
PLoS Pathog. 2009 Jun;5(6):e1000463
pubmed: 19503603
Retrovirology. 2010 Mar 12;7:18
pubmed: 20226045
J Biol Chem. 2006 May 5;281(18):12495-505
pubmed: 16540471
J Virol. 1995 Nov;69(11):6687-96
pubmed: 7474078
J Virol. 2016 Dec 16;91(1):
pubmed: 27795445
J Biol Chem. 2015 Jun 26;290(26):16077-87
pubmed: 25918162
Gene. 1993 Dec 27;137(1):139-43
pubmed: 7506688
Mol Cell. 2001 Jun;7(6):1245-54
pubmed: 11430827
J Biol Chem. 2003 Jan 3;278(1):372-81
pubmed: 12407101
J Virol. 2000 Aug;74(15):6790-9
pubmed: 10888618
J Virol. 2002 Feb;76(3):1004-14
pubmed: 11773376
Oncogene. 2007 Aug 13;26(37):5310-8
pubmed: 17694074
J Biol Chem. 2005 Aug 12;280(32):29334-9
pubmed: 15958388
J Virol. 1996 Mar;70(3):1580-7
pubmed: 8627677
J Virol. 2007 Mar;81(6):3012-7
pubmed: 17182677
J Virol. 1986 Aug;59(2):284-91
pubmed: 3016298
Virology. 2000 Aug 1;273(2):307-15
pubmed: 10915601
J Biol Chem. 2009 Dec 11;284(50):34901-10
pubmed: 19822520
Gene Ther. 1999 May;6(5):715-28
pubmed: 10505094
Antivir Chem Chemother. 2014 Jan 29;23(4):145-9
pubmed: 24318952
J Virol. 2007 Oct;81(20):10914-23
pubmed: 17670825
J Virol. 2011 May;85(10):4654-66
pubmed: 21367893
J Virol. 2005 Aug;79(16):10356-68
pubmed: 16051828
J Virol. 1992 Apr;66(4):2232-9
pubmed: 1548759
J Virol. 1999 Mar;73(3):2126-35
pubmed: 9971795
Nature. 2012 Jul 25;487(7408):482-5
pubmed: 22837004
J Virol. 1995 May;69(5):2729-36
pubmed: 7535863
AIDS Res Hum Retroviruses. 2009 Feb;25(2):207-12
pubmed: 19239360
AIDS. 2004 May 21;18(8):1101-8
pubmed: 15166525
EMBO J. 2006 Jan 11;25(1):139-49
pubmed: 16319923
Protein Sci. 1994 Jun;3(6):888-97
pubmed: 8069220
J Virol. 2004 May;78(10):5056-67
pubmed: 15113887
Cell Host Microbe. 2011 Jun 16;9(6):484-95
pubmed: 21669397
PLoS One. 2014 Aug 19;9(8):e102684
pubmed: 25136952
Virus Genes. 2003 Oct;27(2):177-88
pubmed: 14501196
J Virol. 2004 Nov;78(21):11563-73
pubmed: 15479797
J Virol. 2004 May;78(10):5045-55
pubmed: 15113886
EMBO J. 2007 Dec 12;26(24):4985-95
pubmed: 18007589
J Biol Chem. 2006 Aug 11;281(32):22736-43
pubmed: 16772295
J Virol. 1997 Feb;71(2):1025-35
pubmed: 8995622
EMBO J. 2005 Sep 7;24(17):3070-81
pubmed: 16096645
Curr Genet. 1997 Aug;32(2):157-62
pubmed: 9294265
J Virol. 2010 May;84(10):5181-90
pubmed: 20219923
J Virol. 2009 May;83(10):4749-56
pubmed: 19279091
PLoS One. 2009 Nov 13;4(11):e7825
pubmed: 19915660